Regeneron Pharmaceuticals Stock May Be Worth Buying Again - Rating Upgrade Jun. 25, 2025 9:19 AM ET Regeneron Pharmaceuticals, Inc. (REGN) Stock SNY, AMGN, MRK JNJ PFE JNJ:CA MRK:CA PFE:CA SNYNF ...

FAQ What is Regeneron's matching program for donations? Regeneron launched a program to match donations to Good Days' Retinal Vascular and Neovascular Disease Fund, totaling up to $200 million.

On June 10, 2025, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) received a ‘Hold’ rating from Wells Fargo, which set the company’s stock price target at $580. REGN is one of the 7 52-week ...

This press release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc. (“Regeneron ...

REGN Regeneron Pharmaceuticals, Inc. Stock Price & Overview Analyze With AI Follow 72.7K followers $537.04 2.13 (+0.40%) 9:37 AM 07/02/25 ...

The study’s progress and outcomes could significantly impact Regeneron’s stock performance and investor sentiment, especially if linvoseltamab proves to be more effective than existing treatments.

The franchise drug for autoimmune disorders such as dermatitis could face a challenger: A candidate from Apogee Therapeutics.

Nutrien Ltd. (NYSE:NTR) is one of the 10 best organic food and farming stocks to buy now. On June 26, Morgan Stanley analyst ...

Is Regeneron stock a buy now? Per the terms of the agreement, Regeneron will pay an upfront amount of $80 million, with potential clinical and regulatory milestones of up to $1.93 billion, in ...

Shares of Regeneron Pharmaceuticals Inc. REGN shed 1.24% to $522.68 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.94 ...